| Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group … OA Cornely, A Alastruey-Izquierdo, D Arenz, SCA Chen, E Dannaoui, ... The Lancet infectious diseases 19 (12), e405-e421, 2019 | 1662 | 2019 |
| Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19 A Alanio, S Dellière, S Fodil, S Bretagne, B Mégarbane The Lancet. Respiratory medicine, 2020 | 475 | 2020 |
| Real-Time Identification of Bacteria and Candida Species in Positive Blood Culture Broths by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass … A Ferroni, S Suarez, JL Beretti, B Dauphin, E Bille, J Meyer, ME Bougnoux, ... Journal of clinical microbiology 48 (5), 1542-1548, 2010 | 346 | 2010 |
| Tracing the evolutionary history and global expansion of Candida auris using population genomic analyses NA Chow, JF Muñoz, L Gade, EL Berkow, X Li, RM Welsh, K Forsberg, ... MBio 11 (2), 10.1128/mbio. 03364-19, 2020 | 309 | 2020 |
| ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients J Maertens, S Cesaro, G Maschmeyer, H Einsele, JP Donnelly, A Alanio, ... Journal of Antimicrobial Chemotherapy 71 (9), 2397-2404, 2016 | 299 | 2016 |
| ECIL guidelines for the diagnosis of Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients A Alanio, PM Hauser, K Lagrou, WJG Melchers, J Helweg-Larsen, ... Journal of Antimicrobial Chemotherapy 71 (9), 2386-2396, 2016 | 268 | 2016 |
| Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study JP Gangneux, E Dannaoui, A Fekkar, CE Luyt, F Botterel, N De Prost, ... The Lancet Respiratory Medicine 10 (2), 180-190, 2022 | 257 | 2022 |
| Early diagnosis and monitoring of mucormycosis by detection of circulating DNA in serum: retrospective analysis of 44 cases collected through the French Surveillance Network of … L Millon, R Herbrecht, F Grenouillet, F Morio, A Alanio, V Letscher-Bru, ... Clinical Microbiology and Infection 22 (9), 810. e1-810. e8, 2016 | 250 | 2016 |
| Real-time PCR assay-based strategy for differentiation between active Pneumocystis jirovecii pneumonia and colonization in immunocompromised patients A Alanio, G Desoubeaux, C Sarfati, S Hamane, A Bergeron, E Azoulay, ... Clinical microbiology and infection 17 (10), 1531-1537, 2011 | 240 | 2011 |
| Clinical, Diagnostic, and Treatment Disparities between HIV-Infected and Non-HIV-Infected Immunocompromised Patients with Pneumocystis jirovecii Pneumonia HJF Salzer, G Schäfer, M Hoenigl, G Günther, C Hoffmann, B Kalsdorf, ... Respiration 96 (1), 52-65, 2018 | 215 | 2018 |
| Matrix‐assisted laser desorption ionization time‐of‐flight mass spectrometry for fast and accurate identification of clinically relevant Aspergillus species A Alanio, JL Beretti, B Dauphin, E Mellado, G Quesne, C Lacroix, A Amara, ... Clinical Microbiology and Infection 17 (5), 750-755, 2011 | 207 | 2011 |
| MALDI‐TOF MS‐based drug susceptibility testing of pathogens: The example of Candida albicans and fluconazole C Marinach, A Alanio, M Palous, S Kwasek, A Fekkar, JY Brossas, S Brun, ... Proteomics 9 (20), 4627-4631, 2009 | 183 | 2009 |
| Risk factors associated with COVID-19-associated pulmonary aspergillosis in ICU patients: a French multicentric retrospective cohort S Dellière, E Dudoignon, S Fodil, S Voicu, M Collet, PA Oillic, M Salmona, ... Clinical Microbiology and Infection 27 (5), 790. e1-790. e5, 2021 | 168 | 2021 |
| Low prevalence of resistance to azoles in Aspergillus fumigatus in a French cohort of patients treated for haematological malignancies A Alanio, E Sitterlé, M Liance, C Farrugia, F Foulet, F Botterel, Y Hicheri, ... Journal of antimicrobial chemotherapy 66 (2), 371-374, 2011 | 139 | 2011 |
| Titan cells formation in Cryptococcus neoformans is finely tuned by environmental conditions and modulated by positive and negative genetic regulators B Hommel, L Mukaremera, RJB Cordero, C Coelho, CA Desjardins, ... PLoS pathogens 14 (5), e1006982, 2018 | 129 | 2018 |
| Dynamics of Cryptococcus neoformans-macrophage interactions reveal that fungal background influences outcome during cryptococcal meningoencephalitis in humans A Alanio, M Desnos-Ollivier, F Dromer MBio 2 (4), 10.1128/mbio. 00158-11, 2011 | 127 | 2011 |
| Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients C Cordonnier, S Cesaro, G Maschmeyer, H Einsele, JP Donnelly, ... Journal of Antimicrobial Chemotherapy 71 (9), 2379-2385, 2016 | 124 | 2016 |
| Cryptococcus neoformans host adaptation: toward biological evidence of dormancy A Alanio, F Vernel-Pauillac, A Sturny-Leclère, F Dromer MBio 6 (2), 10.1128/mbio. 02580-14, 2015 | 117 | 2015 |
| Tracing Genetic Exchange and Biogeography of Cryptococcus neoformans var. grubii at the Global Population Level J Rhodes, CA Desjardins, SM Sykes, MA Beale, M Vanhove, ... Genetics 207 (1), 327-346, 2017 | 109 | 2017 |
| Evaluation of serum Mucorales polymerase chain reaction (PCR) for the diagnosis of mucormycoses: the MODIMUCOR prospective trial L Millon, D Caillot, A Berceanu, S Bretagne, F Lanternier, F Morio, ... Clinical Infectious Diseases 75 (5), 777-785, 2022 | 107 | 2022 |
